Vet Med - Czech, 2007, 52(3):121-129 | DOI: 10.17221/2013-VETMED

Influence of the Escherichia coli Nissle 1917 strain on complications of the chronic experimental liver damage

D. Kosakova1, P. Scheer1, J. Lata2,3, J. Doubek1
1 Department of Physiology, Faculty of Veterinary Medicine, Veterinary and Pharmaceutical University, Brno, Czech Republic
2 Internal Clinic of Gastroenterology, Medical Faculty of Masaryk University, Brno, Czech Republic
3 Faculty Hospital, Brno, Czech Republic

The aim of the study was evaluate the influence of the probiotic Escherichia coli Nissle 1917 strain (Mutaflor® suspension, Ardeypharm GmbH, Herdecke, Germany) on bacterial translocation in cases of liver damage, damage to the intestinal mucosa, potential portal hypertension associated with possible development of oesophageal varices and on the bacterial population of the intestine during chronic experimental liver damage in the laboratory rat. Rats with liver damage induced by thioacetamide were divided into an experimental and control group. Experimental and control animals were applied Mutaflor and saline, respectively. Samples of blood, liver, lymph nodes and caecum for microbiological examination, of liver, duodenum and oesophagus for histological examination and of spleen for weight evaluation were collected. There were no significant differences between both groups of animals in the qualitative proportion of Staphylococcus spp., Enterococcus spp. and Proteus spp. cultured from the lymph nodes, blood and liver. The quantitative culture results on Enterococcus spp. in the caecum, liver and lymph nodes showed no significant differences between both groups. There was a significant difference between the experimental and control group in the counts of coliform bacteria. No significant differences between both groups were found in the overall damage score of the liver, duodenum and oesophagus. There were no differences in the spleen to body weight ratio of both groups. The application of Mutaflor® suspension for eight days had no recognisable effect diminishing the selected complications of chronic liver damage caused by the administration of TAA to laboratory rats.

Keywords: bacterial translocation; liver cirrhosis; probiotics; spontaneous bacterial peritonitis; thioacetamide

Published: March 31, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kosakova D, Scheer P, Lata J, Doubek J. Influence of the Escherichia coli Nissle 1917 strain on complications of the chronic experimental liver damage. Vet Med - Czech. 2007;52(3):121-129. doi: 10.17221/2013-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adawi D., Kasravi F.B., Molin G., Jeppsson B. (1997): Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology, 25, 642-647. Go to original source... Go to PubMed...
    2. Albillos A., de la Hera A. (2002): Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants. Journal of Hepatology, 37, 523-526. Go to original source... Go to PubMed...
    3. Bauer T.M., Fernandez J., Navasa M., Vila J., Rodes J. (2002): Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis. Journal of Hepatology, 36, 501-506. Go to original source... Go to PubMed...
    4. Berg R.D. (1992): Bacterial translocation from the gastrointestinal tract. Journal of Medicine, 23, 217-244. Go to PubMed...
    5. Boca M., Vyskocil M., Mikulecky M., Ebringer L., Kolibas E., Kratochvilova H., Buzgova D. (2004): Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies (in Czech). Casopis Lekaru Ceskych, 143, 324-328. Go to PubMed...
    6. Bomba A., Nemcova R., Mudronova D., Guba P. (2002): The possibilities of potentiating the efficacy of probiotics. Trends in Food Science and Technology, 13, 121-126. Go to original source...
    7. Cereto F., Molina I., Gonzalez A., Del Valle O., Esteban R., Guardia J., Genesca J. (2003): Role of immunosuppression in development of quinolone-resistant Escherichia coli spontaneous bacterial peritonitis and in the mortality of E. coli spontaneous bacterial peritonitis. Alimentary Pharmacology & Therapeutics, 17, 695-701. Go to original source... Go to PubMed...
    8. Chiva M., Soriano G., Rochat I., Peralta C., Rochat F., Llovet T., Mirelis B., Schiffrin E.J., Guarner C., Balanzo J. (2002): Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. Journal of Hepatology, 37, 456-462. Go to original source... Go to PubMed...
    9. Chiva M., Guarner C., Peralta C., Llovet T., Gomez G., Soriano G., Balanzo J. (2003): Intestinal mucosal oxidative damage and bacterial translocation in cirrhotic rats. European Journal of Gastroenterology & hepatology, 15, 145-150. Go to original source... Go to PubMed...
    10. Dasarathy S., Mullen K.D., Conjeevaram H.S., KaminskyRuss K., Wills L.A., McCullough A.J. (2002): Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Digestive Diseases and Sciences, 47, 1936-1942. Go to original source... Go to PubMed...
    11. Dupeyron C., Mangeney N., Sedrati L., Campillo B., Fouet P., Leluan G. (1994): Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrobial Agents and Chemotherapy, 38, 340-344. Go to original source... Go to PubMed...
    12. Ersoz G., Aydin A., Erdem S., Yuksel D., Akarca U., Kumanlioglu K. (1999): Intestinal permeability in liver cirrhosis. European Journal of Gastroenterology & Hepatology, 11, 409-412. Go to original source... Go to PubMed...
    13. Fernandez J., Bauer T. M., Navasa M., Rodes J. (2000): Diagnosis, treatment and prevention of spontaneous bacterial peritonitis. Bailliere's best Practice & Research. Clinical Gastroenterology, 14, 975-990. Go to original source... Go to PubMed...
    14. Fernandez J., Navasa M., Gomez J., Colmenero J., Vila J., Arroyo V., Rodes J. (2002): Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology, 35, 140-146. Go to original source... Go to PubMed...
    15. Fevery J., Nevens F. (1999): Treatment of acute oesophageal variceal bleeding: a review. European Journal of Internal Medicine, 10, 140-145. Go to original source...
    16. Fuller R., Gibson G. (2004): Probiotics and prebiotics, definition and role. In: Johnson L.R. (ed.): Encyclopedia of Gastroenterology. Academic Press, San Diego. 1633-1638. Go to original source...
    17. Guarner C., Soriano G. (2005): Bacterial translocation and its consequences in patients with cirrhosis. European Journal of Gastroenterology & Hepatology, 17, 27-31. Go to original source... Go to PubMed...
    18. Guarner C., Runyon B.A., Young S., Heck M., Sheikh M.Y. (1997): Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. Journal of Hepatology, 26, 1372-1378. Go to original source... Go to PubMed...
    19. Hashimoto N., Ohyanagi H. (2002): Effect of acute portal hypertension on gut mucosa. Hepatogastroenterology, 49, 1567-1570. Go to PubMed...
    20. Jett B.D., Huycke M.M., Gilmore M.S. (1994): Virulence of enterococci. Clinical Microbiology Reviews, 7, 462-478. Go to original source... Go to PubMed...
    21. Kaur I. P., Chopra K., Saini A. (2002): Probiotics: potential pharmaceutical applications. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 15, 1-9. Go to original source... Go to PubMed...
    22. Lata J., Jurankova J., Pribramska V., Fric P., Senkyrik M., Dite P., Kroupa R. (2006): Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis (in Czech). Vnitrni Lekarstvi, 52, 215-219. Go to PubMed...
    23. Li X., Benjamin, I.S., Alexander B. (2002): Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality. Journal of Hepatology, 36, 488-493. Go to original source... Go to PubMed...
    24. Liu Q., Duan Z.P., Ha D.K., Bengmark S., Kurtovic J., Riordan S.M. (2004): Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology, 39, 1441-1449. Go to original source... Go to PubMed...
    25. Llovet J. M., Bartoli R., March F., Planas R., Vinado B., Cabre E., Arnal J., Coll P., Ausina V., Gassull M.A. (1998): Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. Journal of Hepatology, 28, 307-313. Go to original source... Go to PubMed...
    26. Misra V., Misra S.P., Dwivedi M., Gupta S.C. (1997): Histomorphometric study of portal hypertensive enteropathy. American journal of clinical pathology, 108, 652-657. Go to original source... Go to PubMed...
    27. Morotomi M., Watanabe T., Suegara N., Kawai Y., Mutai M. (1975): Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats. Infection and immunity, 11, 962-968. Go to original source... Go to PubMed...
    28. Oren R., Dotan I., Brill S., Jones B.E., BenHaim M., Sikuler E., Halpern Z. (1999): Altered thyroid status modulates portal pressure in normal rats. Liver, 19, 423-426. Go to original source... Go to PubMed...
    29. Ouwehand A.C., Pirkka V. Kirjavainen P. V., Shortt C., Salminen S. (1999): Probiotics: mechanisms and established effects. International Dairy Journal, 9, 43- 52. Go to original source...
    30. Pardo A., Bartoli R., Lorenzo-Zuniga V., Planas R., Vinado B., Riba J., Cabre E., Santos J., Luque T., Ausina V., Gassull M.A. (2000): Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology, 31, 858-863. Go to original source... Go to PubMed...
    31. Salminen S., Ouwehand A., Benno Y., Lee Y.K. (1999): Probiotics: how should they be defined? Trends in Food Science and Technology, 10, 107-110. Go to original source...
    32. Such J., Guardiola J. V., de Juan J., Casellas J.A., Pascual S., Aparicio J.R., Sola-Vera J., Perez-Mateo M. (2002): Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. European Journal of Gastroenterology & Hepatology, 14, 371-376. Go to original source... Go to PubMed...
    33. Wells C.L., Maddaus M.A., Simmons R.L. (1989): Bacterial translocation. In: Marston A., Bulkley G.B., Fiddian-Green R.G., Haglund U.H. (eds.): Splanchnic Ischemia and Multiple Organ Failure. The C.V. Mosby Company, St. Louis. 195-204.
    34. Wiest R., Garcia-Tsao G. (2005): Bacterial translocation (BT) in cirrhosis. Hepatology, 41, 422-433. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content